Evidence map›Paper›PMID 16043520›Full record

ArticleThe Journal of experimental medicine2005

Calcium-sensing soluble adenylyl cyclase mediates TNF signal transduction in human neutrophils.

Hyunsil Han, Alexander Stessin, Julia Roberts, Kenneth Hess, Narinder Gautam, Margarita Kamenetsky, Olivia Lou, Edward Hyde, Noah Nathan, William A Muller and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Functional Significance of the Adcy10-Dependent Intracellular cAMP Compartments.Journal of cardiovascular development and disease · 2018
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Targeting G protein coupled receptor-related pathways as emerging molecular therapies.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2015
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Soluble adenylyl cyclase activity is necessary for retinal ganglion cell survival and axon growth.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Hyunsil HanDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA.
Alexander Stessin
Julia Roberts
Kenneth Hess
Narinder Gautam
Margarita Kamenetsky
Olivia Lou
Edward Hyde
Noah Nathan
William A Muller
Jochen Buck
Lonny R Levin
Carl Nathan
Cornell University · USRockefeller University · US

Funding

TWO NOVEL VASCULAR ADHESION MOLECULES: PECAM AND HEC-1R01HL046849 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MULLER, WILLIAM A · 1991 to 2019
$6.7M
BICARBONATE REGULATED ADENYLYL CYCLASER01GM062328 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BUCK, JOCHEN, LEVIN, LONNY R · 2001 to 2013
$4.6M
Beyond PECAM: Mechanisms of Transendothelial MigrationR37HL064774 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MULLER, WILLIAM A · 2005 to 2014
$4.0M
PECAM-INDEPENDENT TRANSENDOTHELIAL MIGRATIONR01HL064774 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI MULLER, WILLIAM A · 2000 to 2020
$3.3M
NEUTROPHIL ACTIVATION IN SEPSIS-- ROLE OF PYK2 PATHWAYR01AI046382 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI NATHAN, CARL F · 2000 to 2004
$2.1M
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLSR01HD038722 · NICHD · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI LEVIN, LONNY R · 2001 to 2004
$1.2M
NHLBI NIH HHS HL46849NHLBI NIH HHS HL64774NHLBI NIH HHS R01 HL046849NHLBI NIH HHS R01 HL064774NHLBI NIH HHS R37 HL064774NIAID NIH HHS AI46382NIAID NIH HHS R01 AI046382NICHD NIH HHS HD38722NICHD NIH HHS HD42060NICHD NIH HHS R01 HD038722NIGMS NIH HHS GM62328NIGMS NIH HHS R01 GM062328
6 · The paper itself

Abstract

Through chemical screening, we identified a pyrazolone that reversibly blocked the activation of phagocyte oxidase (phox) in human neutrophils in response to tumor necrosis factor (TNF) or formylated peptide. The pyrazolone spared activation of phox by phorbol ester or bacteria, bacterial killing, TNF-induced granule exocytosis and phox assembly, and endothelial transmigration. We traced the pyrazolone's mechanism of action to inhibition of TNF-induced intracellular Ca2+ elevations, and identified a nontransmembrane ("soluble") adenylyl cyclase (sAC) in neutrophils as a Ca2+-sensing source of cAMP. A sAC inhibitor mimicked the pyrazolone's effect on phox. Both compounds blocked TNF-induced activation of Rap1A, a phox-associated guanosine triphosphatase that is regulated by cAMP. Thus, TNF turns on phox through a Ca2+-triggered, sAC-dependent process that may involve activation of Rap1A. This pathway may offer opportunities to suppress oxidative damage during inflammation without blocking antimicrobial function.

Indexed as

Adenylyl CyclasesAnti-Inflammatory Agents, Non-SteroidalCalcium SignalingCell DegranulationCells, CulturedCyclic AMPEnzyme ActivationHumansInflammationNeutrophil ActivationNeutrophilsOxidoreductasesPyrazolonesrap1 GTP-Binding ProteinsReceptors, Calcium-SensingTumor Necrosis Factor-alphaAdenylyl CyclasesAnti-Inflammatory Agents, Non-SteroidalCyclic AMPOxidoreductasespyrazolonePyrazolonesRAP1A protein, humanrap1 GTP-Binding ProteinsReceptors, Calcium-SensingTumor Necrosis Factor-alpha

Identifiers

PMID16043520
PMCPMC2213086
OpenAlexW2163697554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.